responses to 5-HT and Ca 2ϩ influx resulting from emptying of Ca 2ϩ stores in the endoplasmic reticulum by thapsigargin were also decreased after PP1 treatment. PP1 significantly reduced the turnover of inositol phosphates produced on 5-HT stimulation and the amount of PIP 2 in the Triton X-100-insoluble lipid fraction. Overall, these data demonstrate that, in rat tracheal smooth muscle cells, Src kinase modulates 5-HT-evoked cell contractility and Ca 2ϩ signaling by regulating PIP 2 levels and Ca 2ϩ influx. phospholipase C; smooth muscle contraction; phosphoinositides IT IS WELL ESTABLISHED that tyrosine kinases activated by ligation of G-protein-coupled receptors (GPCRs) take part in the "cross-talk" with pathways involving mitogen-activated protein kinases. There are also data indicating that tyrosine kinases activated by the stimulation of GPCRs may be involved in Ca 2ϩ signaling (10, 16, 24) . Therefore, in smooth muscle, in which Ca 2ϩ is the main determinant of contraction and in which the majority of contractile agonists act through GPCRs, tyrosine kinases may modulate contractility and potentially contribute to the altered smooth muscle responsiveness observed in such diseases as asthma or hypertension. Indeed, it has been reported that contraction of vascular and airway smooth muscle (ASM) depends, at least partially, on tyrosine kinase activity (3, 4, 28) . However, it is not clear how much of this effect is the result of the modulation of Ca 2ϩ signaling or which tyrosine kinases are involved.
The reputed effects of tyrosine kinase inhibition on Ca 2ϩ responses to a variety of agonists are contradictory, showing a lack of effect on peak Ca 2ϩ response (29) or its inhibition (10, 16) . The mechanisms of these phenomena are not known, with the exception of the events after stimulation of vascular smooth muscle AT 1 receptors, where pp60 Src kinase induces tyrosine phosphorylation and activation of the ␥-isoform of phospholipase C (PLC-␥; see Ref. 11) . However, the majority of GPCRs are known to be linked to the ␤-isoform of PLC (PLC-␤), and activation of 5-HT receptors in rat tracheal smooth muscle cells, as well as of several types of GPCRs in A10 vascular smooth muscle cells, does not appear to result in PLC-␥ tyrosine phosphorylation despite the observed reductions in Ca 2ϩ signals after tyrosine kinase inhibition (6, 24) . Regardless of how and which PLC isoform is activated, the availability of its substrate phosphatidylinositol 4,5-bisphosphate (PIP 2 ) is an important determinant of inositol phosphate production (5, 18) , and it has been reported that PIP 2 levels may be controlled by tyrosine kinase activity (15) . However, the kinase involved in this process was not identified, and the effects of lowering PIP 2 levels by tyrosine kinase inhibitors on Ca 2ϩ signaling were not studied. The effect of tyrosine kinases on the sustained phase of the Ca 2ϩ response to contractile agonists in smooth muscle is equally unclear. Potentiation (25) or inhibition (10) of this phase of the response by tyrosine kinase inhibitors has been described, and tyrosine kinases have been implicated in regulation of voltagedependent L-type Ca 2ϩ channels (30) , nonspecific cation channels (1), and store-operated Ca 2ϩ channels (2) . In the present study, we employed several strategies to clarify the role of Src kinases in GPCR-mediated ASM contraction and Ca 2ϩ signaling, focusing mainly on the effects of Src family kinases on Ca 2ϩ release from the endoplasmic reticulum (ER). First, we confirmed that Src was activated by serotonin (5-HT). Next, we measured 5-HT-evoked Ca 2ϩ transients in cells in which Src was inhibited by a selective inhibitor {4-amino-5(4-methylphenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine (PP1)} or a neutralizing antibody as well as in cells expressing constitutively activated Src. Subsequently, we tested the effects of Src inhibition on inositol phosphate turnover to establish whether Src acted proximally or distally to inositol trisphosphate (IP 3 ) synthesis. Finally, we investigated the effect of Src inhibition on the amount of PIP 2 to establish whether Src played a role in maintaining PLC substrate levels.
MATERIALS AND METHODS
Cell culture. Tracheal smooth muscle cells from 7-to 9-wkold male Fisher rats (Harlan Sprague-Dawley, Walkersville, MD) were isolated and cultured according to previously described methods (24) . Briefly, the cells were enzymatically dissociated with 0.05% elastase type IV and 0.2% collagenase type IV and cultured in 1:1 DMEM-Ham's F-12 medium supplemented with 10% FBS, 0.224% NaHCO3, and 1% penicillin/streptomycin in the presence of 5% CO2. Cell culture reagents were purchased from GIBCO Canada (Mississauga, ON). First-or second-passage cells were rendered quiescent by incubation in medium containing 0.5% FBS for 2-4 days before experiments. Confirmation of a smooth muscle phenotype was based on typical morphology, positive smooth muscle-specific ␣-actin staining, negative keratin staining, and contractile responses to agonists.
Src kinase activity assay. Confluent and growth-arrested cells unstimulated or stimulated for 10 min with 1 M 5-HT were lysed and clarified, and Src kinase was immunoprecipitated with monoclonal anti c-Src antibody (Upstate Biotechnology, Lake Placid, NY) followed by protein G-agarose. Immunoprecipitates from lysates containing 1 mg of protein were washed and resuspended in Src kinase reaction buffer [100 mM Tris ⅐ HCl (pH 7.2), 125 mM MgCl2, 25 mM MnCl2, 2 mM EGTA, 0.25 mM sodium orthovanadate, and 2 mM dithiothreitol] and incubated with the Src-specific substrate peptide (Upstate Biotechnology) and [␥- 32 P]ATP for 10 min at 30°C. Purified Src (15 units; Upstate Biotechnology) was used as a positive control. The reaction was stopped by adding 40% TCA for 5 min. Aliquots (25 l) were spotted on P81 paper, which was allowed to dry. Assay squares were washed with 0.75% phosphoric acid followed by acetone, and radioactivity was measured in the scintillation counter. Activity was expressed as a ratio of counts per minute in the sample from the cells stimulated with 5-HT over control, unstimulated sample.
Measurement of cell contraction. Cells used for contraction measurements were plated on microscopic coverslips with homologous cell substrate (9) and rendered quiescent by serum deprivation at ϳ70% confluence. The cells were incubated for 20 min with 10 M PP1 or with the appropriate vehicle. Images of cells stimulated with 1 M 5-HT or Hanks' buffer were acquired at the rate of one image per minute by using a CCD camera (TM 9701; Pulnix America, Sunnyvale, CA) mounted on a microscope equipped with Nomarski optics (Olympus Optical, Lake Success, NY). The images were digitized and analyzed with Scion software (National Institutes of Health). The surface area of the cells was measured before and 10 min after stimulation. Three experiments were performed with data from 29-36 cells recorded in each experiment.
Cell permeabilization. Confluent and growth-arrested cells on microscope coverslips were temporarily permeabilized by using a previously described method (17) . Briefly, the cells were rinsed with serum-free culture medium and incubated on ice with 1.2 M glycerol in PBS for 10 min followed by an 8-min incubation with lysophosphatidylcholine (Sigma, St. Louis, MO) at a final concentration of 40 g/ml or corresponding volume of vehicle (distilled water). Polyclonal anti-Srcblocking antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or rabbit IgG (1:200) was added for 10 min at 37°C. The cells were transferred to fresh culture medium and allowed to recover for 60 min. Ca 2ϩ responses to 1 M 5-HT were measured by imaging as described below. To confirm that permeabilization and antibody treatments were effective, parallel cell samples were fixed for 10 min in a 1:1 mixture of acetone and methanol, air-dried, and incubated with antirabbit secondary antibody conjugated to fluorescent dye Alexa 488 (Molecular Probes, Eugene, OR) and examined with an Olympus microscope with a confocal attachment (Insight Plus, Meridian, Okemos, MI).
Retroviral infections. Cell populations that express constitutively activated Y529F murine Src were generated by retroviral transduction of smooth muscle cells and selection in the aminoglycoside antibiotic G418. Briefly, the cDNA encoding Y529F murine Src (kindly provided by Dr. D. Shalloway, Cornell University) was transferred to a derivative of the pLXSN retroviral vector (12) to generate pLXSN/Y529FSrc. Recombinant retrovirus encoding Y529F Src was produced by transfecting human embryonic kidney 293T cells with pLXSN/Y529FSrc and a second plasmid encoding the retroviral coat proteins, pSV-⌿-E-MLV. To generate control "empty" virus, 293T cells were transfected with pLXSN only. Later (3 days), cell supernatants containing the retrovirus were collected and stored in aliquots at Ϫ80°C. To generate ASM cells that expressed Y529F Src, first-passage rat tracheal smooth muscle cells (3 ϫ 10 5 ) were plated in 60-mm cell culture dishes. Later (24 h), cells were incubated with recombinant retroviruses in the presence of 4 g/ml polybrene. The next morning, cells were washed two times with PBS and placed in DMEM-F-12 media containing 10% FBS and antibiotics. Later (6 h), the cells were trypsinized and replated on coverslips in six-well dishes. Cells that contained the retroviral DNA were selected by maintaining the cultures in G418 for 7-10 days, at which time multiple G418-resistant colonies were present. Src protein levels and Ca 2ϩ responses to 5-HT in cells, both control and those expressing Y529F Src, were recorded as described below.
SDS-PAGE and Western blotting. Electrophoresis reagents were obtained from Bio-Rad (Mississauga, ON). Populations of control cells infected with pLXSN or those expressing Y529F Src were serum starved overnight, rinsed with ice-cold PBS, lysed with 1 ml of lysis buffer (50 mM HEPES, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EGTA, 1.5 mM MgCl2, 1 mM phenylmethylsulfonyl fluoride, 20 M leupeptin, 15 U aprotinin/ml, and 1 mM sodium orthovanadate), and clarified by centrifugation. Protein concentration was determined, and equal amounts (20 g) were resolved by 10% SDS-PAGE, transferred to 0.22-m pore nitrocellulose filters, and probed with monoclonal antibodies that recognized either activated Src (Biosource International) or total Src (Upstate Biotechnology). Proteins were visualized by using a secondary antibody conjugated to horseradish peroxidase (Amersham) and enhanced chemiluminescence (ECL; Amersham Canada, Oakville, ON) on a FluorChem 8000 imaging system (Alpha Innotech, San Leandro, CA). Ca 2ϩ measurements: imaging. This method was used to measure intracellular free Ca 2ϩ concentration ([Ca 2ϩ ]i) in permeabilized cells, retrovirally transduced cells, and in cells treated with thapsigargin. Cells were loaded with the Ca 2ϩ -sensitive dye fura 2-AM (Molecular Probes) according to previously described methods (21) and imaged by using an intensified camera (Videoscope or IC200) and PTI (Photon Technology International, Princeton, NJ) software at a single emission wavelength (510 nm) with a double excitatory wavelength (345 and 380 nm). The fluorescence ratio (345/380) was measured in cells stimulated with 5-HT after treatment with anti-Src-blocking antibody or rabbit IgG (in permeabilized cells), in retrovirally transduced cells in the presence or absence of PP1, and in thapsigargin-treated cells in the presence or absence of PP1.
To assess the effect of Src inhibition on Ca 2ϩ influx, fura 2-AM-loaded cells were treated with 10 M PP1 or vehicle for 10 min. Ca 2ϩ -containing Hanks' buffer was then replaced by Ca 2ϩ -free Hanks' buffer, 20 M endoplasmic ATPase inhibitor thapsigargin (Sigma) was added, and the fluorescence ratio was monitored. When the ratio stabilized after the initial increase resulting from the depletion of Ca 2ϩ from the sarcoplasmic reticulum, Ca 2ϩ levels in the buffer were restored, and the fluorescence ratio was recorded. [Ca 2ϩ ]i was calculated according to the formula of Grynkiewicz et al. (7) . The dissociation constant was assumed to be 224 nM, mean maximal fluorescence ratio (Rmax; 345/380 fluorescence ratio of Ca 2ϩ -saturated cells, measured in cells exposed to 10 Ϫ5 M ionomycin/Hanks' buffer) was 3.23, the minimum fluorescence ratio (Rmin; 345/380 fluorescence ratio of Ca 2ϩ -free cells measured in cells exposed to 10 Ϫ5 M ionomycin and 10 Ϫ6 M EGTA in Ca 2ϩ -free buffer) was 0.61, and the ratio of fluorescence at 380 nm excitation wavelength in Ca 2ϩ -free and Ca 2ϩ -saturated cells (B) was 2.43. Ca 2ϩ measurements: photometry. The effects of pharmacological inhibition of Src kinases on Ca 2ϩ transients were measured by using microscope-based photometry. The cells were exposed to PP1 or an equivalent volume of vehicle for 10 min before the administration of 1 M 5-HT. Fluorescence of a small sample (3-5) of cells was recorded at the rate of 20 points/s by using a D401 microphotometer and PTI software. Background fluorescence was automatically subtracted. Rmax measured with this method was 7.6, Rmin was 0.55, and B was 8.89. Three experiments were conducted, with three samples for each treatment per experiment.
Measurement of inositol phosphates. Confluent cells plated on 60-mm-diameter dishes were growth arrested and radiolabeled for 48 h with inositol-free DMEM containing 0.5% FBS and 1 Ci/ml myo-[ 3 
H]inositol (Amersham Canada). Cells were washed free of unincorporated myo-[
3 H]inositol with Krebs-Henseleit buffer (KHB; 117 mM NaCl, 4.7 mM KCl, 1.1 mM MgSO4, 1.2 mM KH2PO4, 20 mM NaHCO3, 2.4 mM CaCl2, 1 mM glucose, and 20 mM HEPES) and preincubated with 10 mM LiCl in 1 ml PBS at 37°C for 10 min with or without 10 M PP1. The cells were challenged with 5-HT in the presence of LiCl for 10 min at 37°C. Stimulation was terminated by the addition of ice-cold 3 M TCA. Cells were chilled on ice for 30 min and then scraped off the dishes. After sonication, cellular debris was removed by centrifugation at 4,000 g for 5 min at 4°C. The inositol polyphosphates were extracted with 10 mM EDTA-trichlorotrifluoroethane-tri-noctylamine (1:2:2), and the aqueous and organic fractions were separated by centrifugation. The aqueous layer was neutralized with 60 mM NaHCO3 and assayed for total myo- [ 3 H]inositol phosphates by anion exchange chromatography. Samples were loaded on columns containing Phosphoinositide analysis. Confluent cells cultured on 150-mm dishes were labeled with 2.5 Ci/ml myo-[
3 H]inositol in inositol-free DMEM containing 0.5% FBS for 48 h. Cells were washed with KHB, incubated with 10 M PP1 or the vehicle for 10 min, washed two times with ice-cold PBS, and scraped from the plates in 1 ml PBS. To extract lipids, cells were centrifuged at 10,000 g for 5 min, and the cell pellet was resuspended in 400 l Triton extraction buffer [25 mM HEPES (pH 7.2), 250 mM NaCl, 2 mM MgCl 2, 2 mM MnCl2, 1 mM CaCl2, and 0.5% Triton X-100] and incubated for 20 min at 4°C with mixing as described previously (18) . Lysates were centrifuged at 15,000 g for 10 min, and the supernatant was collected as the Triton-soluble fraction to which 400 l of stop solution (methanol-concentrated HCl, 10:1 vol/vol) was added. The Triton-insoluble pellet was washed two times with PBS, and 200 l of stop solution and 200 l of PBS were added. Lipids from Triton-soluble and Triton-insoluble fractions were extracted by using chloroform-methanol (1:1 vol/ vol). Samples were centrifuged at 15,000 g for 2 min at 4°C, and the lower phase containing phosphoinositides was collected. After reducing the solvent volume of the sample to ϳ100 l under vacuum, the samples were applied with a glass capillary on potassium oxalate-impregnated silica gel thin-layer chromatography plates. Potassium oxalate plates were prepared by placing silica gel plates (Analtech, Newark, DE) in a 1% potassium oxalate solution in methanol-water (60:40 vol/vol) for ϳ30 min. After being dried in the fume hood for ϳ1 h, the plates were dried in a 110°C oven for 15-20 min and stored in a low-humidity cabinet. The plates were developed in chloroform-acetone-methanol-acetic acidwater (40:15:13:12:8 vol/vol/vol/vol/vol). Chromatographed lipids were localized by iodine staining and identified by migration with the following authentic standards: phosphatidylinositol, phosphatidylinositol 4-phosphate, and PIP 2. Lipids were scraped from the plates, and 3 H radioactivity was measured by using a scintillation counter. Four independent experiments were conducted, and the amount of PIP 2 was expressed as a percentage of the total counts.
Statistical analysis. Statistical analysis was performed by using unpaired Student's t-test, and P values of Յ0.05 were considered as statistically significant.
RESULTS

Src activity regulates 5-HT-induced ASM cell contraction.
Src kinase activity assays revealed that Src kinase activity was approximately threefold greater in immunoprecipitates from the cells stimulated with 1 M 5-HT for 10 min compared with immunoprecipitates from unstimulated cells (Fig. 1) . The same stimulation procedure resulted in protein tyrosine phosphorylation that was reduced by incubation with 10 M PP1, the selective Src inhibitor (data not shown).
To determine whether Src family kinases modulated contraction of smooth muscle cells, changes in the surface area evoked by 5-HT in the presence of PP1 or appropriate vehicle were assessed. To distinguish between the effects caused by the contractile agonist acting through signaling initiated at GPCRs and those caused by a mechanical stimulus (addition of the solution), changes in cell area triggered by the addition of the buffer alone were also assessed. The application of 5-HT caused a significant decrease in cell area (19.4 Ϯ 2.5%), but there was also a small decrease in cell area (6.3 Ϯ 1.6%) after addition of Hanks' buffer alone. PP1 treatment blocked the decrease in cell area triggered by both stimuli, but the effect on the 5-HT response was more pronounced. The change in area caused by 5-HT in the presence of PP1 was not significantly different from the change caused by the buffer alone (1 Ϯ 1.5 and 2.1 Ϯ 1.2%, respectively; Fig. 2 PP1 inhibits several Src family kinase members and thus cannot be used to specifically define a role for pp60 Src in this system. To determine whether pp60 Src ] i in cells exposed to anti-Src antibody but not permeabilized did not differ from the control, untreated cells (Fig. 4A) . Immunocytochemistry confirmed that permeabilization was successful because anti-Src antibody and IgG were detected inside permeabilized cells incubated with anti-Src or IgG antibodies, respectively (Fig. 4B, a and b) .
To confirm the role of Src kinases in Ca 2ϩ signaling, cell populations expressing constitutively activated Y529F murine Src were generated. Tracheal smooth muscle cells were infected with recombinant retroviruses encoding Y529F Src or with control empty retroviruses. Transduced cells were selected by culturing cells in the aminoglycoside antibiotic G418. The status of Src activation in the cells was assessed by immunoblot analysis by using an antibody that recognizes activated Src, phosphorylated on tyrosine residue 416. The levels of Tyr-phosphorylated Src in cells expressing Y529F were significantly elevated compared with control cells (Fig. 5A) . Total Src protein levels were also elevated, although not dramatically. Similarly, after 5-HT stimulation, peak and plateau [Ca 2ϩ ] i were significantly higher in Y529F Src-expressing cells (517.96 Ϯ 15.17 and 230.81 Ϯ 4.82 nM, respectively) compared with control cells (145.05 Ϯ 9.74 and 107.39 Ϯ 2.55 nM). Moreover, pretreatment of cells with 10 M PP1 significantly decreased both peak and sustained Ca 2ϩ responses to 5-HT in control cells (infected with empty virus) to 101.98 Ϯ 4.98 nm (peak) and 91.32 Ϯ 4.12 nm (plateau) and in Y529F Srcexpressing cells to 297.78 Ϯ 14.99 nm (peak) and 122.11 Ϯ 2.446 nm (plateau; Fig. 5B) .
Src regulates production of inositol phosphate production and PIP 2 . To establish which step of Ca 2ϩ release from the ER was affected by Src kinase, the production of inositol phosphates triggered by 5-HT was measured in the presence and absence of 10 M PP1. 5-HT induced an almost threefold increase in inositol phosphate turnover (286% of basal level). PP1 had no effect on the basal level of inositol phosphates (106% of control) but significantly reduced the quantity of inositol phosphates produced on 5-HT stimulation (150% of basal level; Fig. 6 ). Inositol phosphate production reflects PLC activity, which in turn depends on the availability of the substrate PIP 2 (5) . Because tyrosine kinase inhibition may significantly reduce levels of PIP 2 (15) , amounts of PIP 2 in control and PP1 (10 M)-treated cells were measured. No effect of PP1 was detected when the whole pool of phosphoinositides was assayed (data not shown). Therefore, PIP 2 levels in Triton-soluble and Triton-insoluble fractions, representing primarily solubilized plasma membrane and caveolae, respectively, were assessed. Approximately 40% of PIP 2 was localized to the Triton-insoluble fraction (PIP 2 accounted for 9.7% of total counts in the Triton-soluble and 6.1% of total counts in the Tritoninsoluble fraction). A significant decrease in PIP 2 levels in PP1-treated samples in the Triton-insoluble fraction was observed (from 6.1 Ϯ 1% total counts to 3.4 Ϯ 0.3%), with no significant change in the Triton-soluble fraction (9.7 Ϯ 1 and 12 Ϯ 1.6%; Fig. 7 ). Thus the results suggest that inhibition of Src family kinases reduces inositol phosphate production levels by decreasing PIP 2 levels in the Triton-insoluble fraction.
DISCUSSION
The role and identity of tyrosine kinases in inositol phosphate/Ca 2ϩ signaling initiated by GPCRs remain poorly defined. It is generally recognized that binding of a contractile agent to a GPCR is followed by the activation of PLC, leading to the production of the following two second messengers: IP 3 and diacylglycerol. IP 3 interacts with its receptors on the ER, causing a release of Ca 2ϩ from intracellular stores followed by Ca 2ϩ influx from the extracellular milieu. An increase in [Ca 2ϩ ] i is necessary for the initiation of many processes and is of particular importance in smooth muscle, where Ca 2ϩ plays a key role in contraction. Enhanced Ca 2ϩ mobilization and contraction of ASM may contribute to airway hyperresponsiveness (21) . Several studies have shown that inhibition of tyrosine kinases impairs the ability of gastric, vascular, and ASM rings or strips to contract on stimulation with agonists acting on GPCRs (3, 4, 28) . Using cultured ASM cells to avoid the possible compounding effects of other cells present in these preparations, we have shown that tyrosine kinases may have a direct effect on ASM contraction and Ca 2ϩ signaling evoked by 5-HT (24) . Our data from the present study, also conducted on cultured cells, have identified the kinase as a member of the Src family, based on the observations that PP1, a specific inhibitor of several members of the Src kinase family, caused a decrease in both cell contraction and Ca 2ϩ mobilization induced by 5-HT. Furthermore, our data implicate pp60 Src directly in these phenomena because anti-pp60 Src blocking antibody had a similar effect on peak Ca 2ϩ responses to 5-HT as did PP1, although maximal responses in the former experiment were lower overall than in the latter. This difference might result either from the lower sensitivity of the imaging system (used in antibody neutralization experiments) than photometry (used to test PP1) or from the permeabilization procedure. The role of Src in Ca 2ϩ mobilization is further supported by our observation that expression of constitutively activated Y529F Src significantly increased peak and sustained responses to 5-HT.
Our data show that both peak and plateau phases of the Ca 2ϩ response to 5-HT were affected by modulating the activity or the expression of Src kinase. We have previously reported that these phases correspond to the release of Ca 2ϩ from ER and entry of Ca 2ϩ from the extracellular milieu and that the sustained phase of the response has characteristics of store-operated Ca 2ϩ influx (23) . We conclude, therefore, that Src kinase mediates IP 3 -induced Ca 2ϩ release from the ER and Ca 2ϩ influx resulting from emptying of intracellular stores. These data are consistent with previous reports showing that tyrosine kinase inhibition led to a decrease of peak and sustained Ca 2ϩ responses to contractile agonists in vascular and ASM (10, 16, 24) . Moreover, Ca 2ϩ entry triggered by bradykinin or thapsigargin is dramatically lower in embryonic fibroblasts from Src-deficient mice compared with cells from wildtype animals. Significantly, Ca 2ϩ entry is restored to nearly normal levels by transfecting Src-deficient cells with a c-Src expression plasmid (2) . Nevertheless, the mechanism(s) by which tyrosine kinase(s) regulate GPCR-induced Ca 2ϩ entry are poorly defined and probably also depend on the receptor that is activated and in which cell type it is expressed. For example, inhibition of tyrosine kinases by tyrphostin A-23 in rat vascular smooth muscle resulted in a prolonged, sustained [Ca 2ϩ ] i elevation after ANG II application (25) . The identity of the Ca 2ϩ channels involved in tyrosine kinase-sensitive Ca 2ϩ influx is also not well established. It has been reported that agents that increase tyrosine phosphorylation activate a nonselective cation channel (1). Src is implicated in modulation of Ca 2ϩ influx through both store-operated channels (2) and L-type Ca 2ϩ channels (30) . Ca 2ϩ release from the ER critically depends on PLC activity. It has been reported that, in vascular smooth muscle, pp60 Src kinase induces the activation of PLC-␥ on AT 1 receptor stimulation (11) . Although Ca 2ϩ responses were not described in this study, it is well established that activation of PLC-␥ leads to an increase in [Ca 2ϩ ] i by the same sequence of events as activation of PLC-␤, namely by IP 3 production and Ca 2ϩ release from the ER. However, the only functional 5-HT receptor expressed in rat ASM cells has been identified as 5-HT 2c (23) , and this type of receptor is known to activate PLC-␤. Moreover, we have previously reported (24) that stimulation of rat ASM with 5-HT does not result in detectable PLC-␥ phosphorylation, which is usually necessary for its activation. Similarly, in A10 vascular smooth muscle cells, peak Ca 2ϩ responses triggered by several agonists were significantly attenuated by tyrosine kinase inhibition, whereas stimulation with these agonists did not result in PLC-␥ phosphorylation (6) . Nevertheless, our present study revealed that Src inhibition by PP1 resulted in the diminished production of inositol phosphates. This effect could be explained by the ability of Src to modulate the amount of PLC substrate, PIP 2 . It has been previously reported that tyrosine kinase inhibition leads to a rapid decrease of cellular PIP 2 levels in HEK-293 cells (15) . The resynthesis of PIP 2 occurs in a sustained fashion in nonstimulated cells and very rapidly after PLC hydrolysis (26) . Therefore, PIP 2 resupply is required for PLC-mediated inositol phosphate production (5) . Indeed, our results show that inhibition of Src by PP1 leads to a decrease in PIP 2 levels in the Triton-insoluble fraction. This observation is consistent with previous studies showing that, in A431 cells, epidermal growth factor and bradykinin caused a 50% decrease in PIP 2 levels in the caveolinrich, Triton-insoluble fraction but no change in the levels of total plasma membrane PIP 2 (8, 14) . Also consistent with this study are our results indicating that ϳ40% of PIP 2 recovered from rat ASM resides in these agonist-sensitive regions.
Although we have observed a significant effect of Src kinase on Ca 2ϩ signaling, it is possible that Src may additionally modulate ASM contractility by other mechanisms such as cytoskeletal rearrangement. It could occur in a PIP 2 -dependent fashion because PIP 2 may bind and thereby regulate a variety of actinbinding proteins (22) , or by regulation of tyrosine phosphorylation of proteins in dense plaques (13, 20, 27) . Such a possibility is supported by our observation that changes in the cell area triggered by the application of buffer alone were inhibited by PP1, even if the administration of the buffer did not cause an increase in [Ca 2ϩ ] i (data not shown). In summary, our data demonstrate that Src kinase modulates ASM contraction and Ca 2ϩ signaling. The mechanism of the effect involves a reduction in inositol phosphate turnover that may be a consequence of alterations in agonist-sensitive pools of the PLC substrate PIP 2 .
